Insider · CIK 0001297491
Thunen Shelley B
Reports to the SEC for 6 companies · IRVINE, CA
Transactions
50
Companies
6
Filings
11
CIK
0001297491
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-17 | AEONAEON Biopharma, Inc.A Award | — |
| 2026-06-15 | LENZLENZ Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2025-06-11 | LENZLENZ Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2025-05-21 | AEONAEON Biopharma, Inc. · Restricted Stock UnitsA Award | — |
| 2025-04-14 | RXSTRxSight, Inc.M Exercise/Conversion | +$33.8K |
| 2025-04-14 | RXSTRxSight, Inc. · Stock Option (right to buy)M Exercise/Conversion | — |
| 2025-04-14 | RXSTRxSight, Inc. · Stock Option (right to buy)M Exercise/Conversion | — |
| 2025-02-27 | RXSTRxSight, Inc. · Stock Option (right to buy)A Award | — |
| 2024-10-01 | RXSTRxSight, Inc.M Exercise/Conversion | +$240K |
| 2024-10-01 | RXSTRxSight, Inc.S Sale | −$249K |
| 2024-10-01 | RXSTRxSight, Inc.S Sale | −$464K |
| 2024-10-01 | RXSTRxSight, Inc.S Sale | −$13.7K |
| 2024-10-01 | RXSTRxSight, Inc. · Stock option (right to buy)M Exercise/Conversion | — |
| 2024-08-31 | AEONAEON Biopharma, Inc.A Award | — |
| 2024-08-31 | AEONAEON Biopharma, Inc. · Stock OptionA Award | — |
| 2024-08-07 | RXSTRxSight, Inc. · Stock Option (right to buy)A Award | — |
| 2024-07-15 | RXSTRxSight, Inc.M Exercise/Conversion | +$71.6K |
| 2024-07-15 | RXSTRxSight, Inc. · Stock Option (right to buy)M Exercise/Conversion | — |
| 2024-07-15 | RXSTRxSight, Inc. · Stock Option (right to buy)M Exercise/Conversion | — |
| 2024-07-01 | RXSTRxSight, Inc.M Exercise/Conversion | +$156K |
| 2024-07-01 | RXSTRxSight, Inc.S Sale | −$476K |
| 2024-07-01 | RXSTRxSight, Inc.S Sale | −$110K |
| 2024-07-01 | RXSTRxSight, Inc.S Sale | −$386K |
| 2024-07-01 | RXSTRxSight, Inc.S Sale | −$107K |
| 2024-07-01 | RXSTRxSight, Inc. · Stock Option (right to buy)M Exercise/Conversion | — |
| 2024-05-01 | RXSTRxSight, Inc.M Exercise/Conversion | +$160K |
| 2024-05-01 | RXSTRxSight, Inc.S Sale | −$507K |
| 2024-05-01 | RXSTRxSight, Inc.S Sale | −$20.2K |
| 2024-05-01 | RXSTRxSight, Inc. · Stock Option (right to buy)M Exercise/Conversion | — |
| 2024-04-01 | RXSTRxSight, Inc.S Sale | −$441K |
| 2024-04-01 | RXSTRxSight, Inc.S Sale | −$40.2K |
| 2024-04-01 | RXSTRxSight, Inc.S Sale | −$445K |
| 2024-04-01 | RXSTRxSight, Inc.S Sale | −$33.3K |
| 2024-04-01 | RXSTRxSight, Inc.S Sale | −$10.1K |
| 2024-04-01 | RXSTRxSight, Inc.S Sale | −$28K |
| 2024-03-21 | LENZLENZ Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2024-03-19 | AEONAEON Biopharma, Inc. · Stock OptionA Award | — |
| 2024-03-04 | RXSTRxSight, Inc. · Stock Option (right to buy)A Award | — |
| 2024-03-01 | RXSTRxSight, Inc.M Exercise/Conversion | +$156K |
| 2024-03-01 | RXSTRxSight, Inc.S Sale | −$64.1K |
| 2024-03-01 | RXSTRxSight, Inc.S Sale | −$359K |
| 2024-03-01 | RXSTRxSight, Inc.S Sale | −$141K |
| 2024-03-01 | RXSTRxSight, Inc. · Stock Option (right to buy)M Exercise/Conversion | — |
| 2024-02-06 | RXSTRxSight, Inc.M Exercise/Conversion | +$237K |
| 2024-02-06 | RXSTRxSight, Inc.S Sale | −$754K |
| 2024-02-06 | RXSTRxSight, Inc. · Stock Option (right to buy)M Exercise/Conversion | — |
| 2024-02-05 | RXSTRxSight, Inc.M Exercise/Conversion | +$29.9K |
| 2024-02-05 | RXSTRxSight, Inc.M Exercise/Conversion | +$136K |
| 2024-02-05 | RXSTRxSight, Inc.S Sale | −$429K |
| 2024-02-05 | RXSTRxSight, Inc. · Stock Option (right to buy)M Exercise/Conversion | — |
Recent filings
- 4Thunen Shelley B0001104659-26-076515SEC(opens sec.gov)
- 4Thunen Shelley B0001297491-26-000001SEC(opens sec.gov)
- 4Thunen Shelley B0001815776-25-000045SEC(opens sec.gov)
- 4Thunen Shelley B0001610717-25-000141SEC(opens sec.gov)
- 4Thunen Shelley B0000950170-25-054439SEC(opens sec.gov)
- 4Thunen Shelley B0000950170-25-029396SEC(opens sec.gov)
- 4Thunen Shelley B0000950170-24-111461SEC(opens sec.gov)
- 4Thunen Shelley B0001104659-24-097060SEC(opens sec.gov)
- 4Thunen Shelley B0000950170-24-093972SEC(opens sec.gov)
- 4Thunen Shelley B0000950170-24-084038SEC(opens sec.gov)
- 4Thunen Shelley B0000950170-24-080522SEC(opens sec.gov)
Companies
Address
C/O AEON BIOPHARMA, INC. 5 PARK PLAZA, SUITE 1750
IRVINE, CA, 92614